TABLE 3.
Characteristics of transplant recipients getting COVID‐19 pre‐transplant
| S.No | Age (in years) | Gender | Disease severity | Symptoms at presentation | Hospitalization requirement | Treatment given | Days after first positivity to transplantation |
|---|---|---|---|---|---|---|---|
| 1 | 7 | M | Asymptomatic | None | No | None | 90 |
| 2 | 32 | M | Mild | Fever | Yes | R/S | 39 |
| 3 | 47 | M | Moderate | Fever | Yes | A/Az/F/S | 75 |
| 4 | 23 | M | Asymptomatic | None | No | None | 24 |
| 5 | 34 | M | Asymptomatic | None | No | None | 15 |
| 6 | 42 | M | Moderate | Fever, cough, breathlessness, myalgia | yes | A/S | 81 |
| 7 | 39 | M | Asymptomatic | None | No | None | 37 |
| 8 | 43 | M | Asymptomatic | None | No | None | 48 |
| 9 | 46 | M | Asymptomatic | None | No | None | 50 |
| 10 | 49 | M | Severe | Fever, cough, breathlessness, myalgia | yes | A/R/S | 107 |
| 11 | 18 | M | Severe | Fever, cough, breathlessness, myalgia | yes | A/R/S | 65 |
| 12 | 29 | M | Moderate | Fever, breathlessness, myalgia | yes | A/R/S | 108 |
Abbreviations: A, anticoagulant; Az, azithromycin; F, favipiravir; R, remdesivir; S, steroid; M, male.